John Wiley & Sons Inc
NYSE:WLY

Watchlist Manager
John Wiley & Sons Inc Logo
John Wiley & Sons Inc
NYSE:WLY
Watchlist
Price: 36.35 USD -0.63% Market Closed
Market Cap: $1.9B

John Wiley & Sons Inc
Investor Relations

In the bustling world of academic and professional publishing, John Wiley & Sons Inc. stands as a venerable figure, weaving its narrative through more than two centuries of innovation and adaptation. Established in 1807, Wiley initially carved its niche by publishing works from some of the brightest minds of the 19th century, including definitive texts by the likes of Herman Melville and Edgar Allan Poe. Over the years, the company gracefully transitioned from traditional print to digital realms, ensuring its survival and relevance in a rapidly changing industry. Today, Wiley is a leading global provider of content and workflow solutions in areas of scientific, technical, medical, and scholarly research, as well as in education. Through its robust portfolio of journals, books, and digital content, the company fuels the progress of knowledge and learning across the globe.

At the heart of its business model, Wiley generates revenue by selling subscriptions to its academic journals, licensing its digital resources, and offering educational materials such as textbooks and supplementary learning tools. These revenue streams are amplified by its online platforms, which offer a blend of open-access content and paywalled resources, catering to the diverse needs of individuals, institutions, and corporations. By balancing the access and monetization of cutting-edge research, Wiley has established itself as a key player in advancing the frontiers of science and scholarship while maintaining a healthy bottom line. This dual commitment to business growth and educational advancement underscores Wiley's enduring legacy and its crucial role in the dissemination of knowledge.

Show more
Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Last Earnings Call
Fiscal Period
Q3 2026
Call Date
Mar 5, 2026
AI Summary
Q3 2026

Quarter result: Q3 was in line with expectations — revenue essentially flat at constant currency, with Research strength offsetting softness in Learning.

Research momentum: Research publishing outpaced the market — submissions up 26%, global output up 11%, and publishing revenue up 4% excluding AI.

AI ramp: AI and data revenue is accelerating — $42 million year-to-date, $7 million recognized in the quarter, and company guidance of $45–$50 million for fiscal '26.

Margins & cash: Continued margin expansion and cash generation — adjusted operating margin up 280 bps in the quarter, adjusted EBITDA margin up 250 bps, and operating cash flow nearly doubled to $103 million.

Cost & transformation: Tech transformation and outsourcing (Virtusa) are driving corporate cost savings (corporate costs down 21% this quarter on an adjusted EBITDA basis) and expected further margin benefits.

Capital returns: Buybacks stepping up — $70 million repurchased year-to-date, $100 million full-year target; $126 million returned in dividends and buybacks in nine months.

Outlook: Raising margin and EPS guidance to the high end of prior ranges; revenue growth expected low single-digits and free cash flow reaffirmed at ~ $200 million.

Key Financials
Revenue (company-wide, Q3)
up 1% reported, flat at constant currency
Research (Q3)
up 1%
Research Publishing (ex-AI)
up 4%
Submissions
up 26%
Global output
up 11%
AI revenue (quarter)
$7 million
AI revenue (year-to-date)
$42 million
AI revenue (fiscal '25)
$40 million
AI revenue (fiscal '24)
$23 million
Adjusted operating margin (Q3)
up 280 basis points
Adjusted EBITDA margin (Q3)
up 250 basis points
Adjusted operating income
up 22%
Adjusted EPS (Q3)
up 19%
Adjusted EBITDA (Q3)
up 12%
Operating cash flow (Q3)
$103 million
Free cash flow (guidance)
approximately $200 million
CapEx (prior year)
$77 million
Corporate expense (adjusted EBITDA basis)
down 21% in the quarter, down 12% year-to-date
Total returned to shareholders (9 months)
$126 million
Leverage (net debt / EBITDA)
1.7 (down from 2.0)
Advanced portfolio revenue (fiscal '26)
will exceed $70 million
Clinical Outcome Assessments (COA) catalog
nearly 7 million (vs 800,000 in 2021)
Gateway registrations
9,000 researchers registered
Virtusa contract size
roughly $150 million over 5 years
Dividend yield
approximately 4.5%
Earnings Call Recording
Other Earnings Calls

Management

Mr. Jesse Caleb Wiley
Non-Executive Chairman
No Bio Available
Mr. Matthew S. Kissner
President, CEO & Employee Director
No Bio Available
Ms. Danielle McMahan
Executive VP & Chief People Officer
No Bio Available
Mr. James Flynn
Executive VP and GM of Research & Learning
No Bio Available
Mr. Christopher F. Caridi
Interim CFO, Senior VP, Chief Accounting Officer & Global Corporate Controller
No Bio Available
Mr. Brian Campbell
Vice President, Investor Relations
No Bio Available
Mr. Josh Jarrett
Senior Vice President of Strategy
No Bio Available

Contacts

Address
NEW JERSEY
Hoboken
111 River St
Contacts
+12017486000.0
www.wiley.com
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett